PLD Acquisitions

Padagis is a leading pharmaceutical company specializing in the development, manufacturing, and distribution of generic prescription medicines, with a dominant market position in topical treatments. The company was established in 2021 following the $1.55 billion acquisition of Perrigo Company's generic prescription pharmaceuticals business by Altaris Capital Partners, initially operating under the legal name PLD Acquisitions LLC. Padagis maintains an extensive portfolio of over 200 product families, including specialized formulations such as creams, ointments, gels, and nasal sprays. With major operations in the United States and Israel, the company focuses on providing affordable access to high-quality specialized healthcare products across therapeutic areas like dermatology, women's health, and respiratory care. Padagis is one of the largest employers in the generic pharmaceutical sector in Michigan and continues to expand its pipeline through complex generic R&D.